Clinical trial
Safety and Tolerance of an Intermittent Intervention in MS Patients
NCT04635033 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Tolerance of an Intermittent Intervention in MS Patients
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 19, 2018
- Completion date
- October 10, 2019
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.